Skip to content
Screener

Gilead Sciences GILD Q1 2025 earnings

Reported April 24, 2025 · After market close

Revenue$6.7BMiss by $143.9M
EPS$1.81Beat by $0.03
Revenue estimate$6.8B
EPS estimate$1.78

Next report

Oct 29, 2026 (In 3 weeks)
Revenue estimate$7.8B
EPS estimate$2.12

Financials

Q1 2025

Income statement

See full
Revenue$6.7B-0.3%
Gross profit$5.1B-0.1%
Operating income$2.2B+152%
Net income$1.3B+132%
EPS (diluted)$1.04+131%

Balance sheet

See full
Cash & equivalents$7.9B+68.0%
Total debt$25.0B-1.0%
Total equity$19.2B+9.3%
Total assets$56.4B+0.3%

Cash flow

See full
Operating cash flow$1.8B-20.8%
CapEx$104.0M-1.0%
Free cash flow$1.7B-21.8%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$139.69B+53.1%
Enterprise value$156.71B+40.3%
P/E23.4×-165×
P/S4.9×+1.5×

Profitability

See full
Gross margin78.3%+2.5pp
Operating margin28.6%+22.9pp
Net margin20.8%+19.0pp
FCF margin34.3%+5.5pp

Returns & leverage

See full
Return on equity32.5%+30.0pp
Debt / equity1.3×-0.1×
Current ratio1.4×+0.3×

Segments

By product

See full
Biktarvy$3.2B+6.9%
Descovy$586.0M+37.6%
Yescarta$386.0M+1.6%
Genvoya$364.0M-9.7%
Sofosbuvir/Velpatasvir$346.0M-14.6%

By geography

See full
Europe$1.1B-6.5%
Rest of World$915.0M+2.3%

FAQ

When did Gilead Sciences report Q1 2025 earnings?
Gilead Sciences (GILD) reported Q1 2025 earnings on April 24, 2025 after market close.
What were Gilead Sciences's Q1 2025 revenue and EPS?
Gilead Sciences reported revenue of $6.7B and eps of $1.81 for Q1 2025.
Did Gilead Sciences beat estimates in Q1 2025?
Revenue missed the consensus estimate of $6.8B by $143.9M. EPS beat the consensus estimate of $1.78 by $0.03.
How did Gilead Sciences's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 0.3% from $6.7B a year earlier.
Where can I find Gilead Sciences's Q1 2025 SEC filings?
You can read the 8-K earnings release (0000882095-25-000009) and the 10-Q periodic report (0000882095-25-000012) directly on SEC EDGAR. The filing index links above go to sec.gov.